EUVIMEDEUVIMED entdecken
Open Access

MAFB in Macrophages Regulates Prostaglandin E2–Mediated Lipid Mediator Class Switch through ALOX15 in Ischemic Acute Kidney Injury

Maho Kanai iD, Teppei Nishino iD, Dhouha Daassi iD, Akari Kimura, Ching-Wei Liao iD, Zeynab Javanfekr Shahri iD, Arata Wakimoto iD, Natalia Gogoleva iD, Toshiaki Usui iD, Naoki Morito iD, Makoto Arita, Satoru Takahashi iD und 1 weitere

The Journal of Immunology · 2024

DOI: 10.4049/jimmunol.2300844 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, 2024. Verfasst von Maho Kanai und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy and Embryology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan. Hauptthemen laut MEDLINE: MafB Transcription Factor, Arachidonate 15-Lipoxygenase, Acute Kidney Injury, Macrophages. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ministry of Education, Culture, Sports, Science and Technology (MEXT), MEXT | Japan Science and Technology Agency (JST).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Monocytes and macrophages express the transcription factor MAFB (V-maf musculoaponeurotic fibrosarcoma oncogene homolog B) and protect against ischemic acute kidney injury (AKI). However, the mechanism through which MAFB alleviates AKI in macrophages remains unclear. In this study, we induced AKI in macrophage lineage-specific Mafb-deficient mice (C57BL/6J) using the ischemia-reperfusion injury model to analyze these mechanisms. Our results showed that MAFB regulates the expression of Alox15 (arachidonate 15-lipoxygenase) in macrophages during ischemic AKI. The expression of ALOX15 was significantly decreased at the mRNA and protein levels in macrophages that infiltrated the kidneys of macrophage-specific Mafb-deficient mice at 24 h after ischemia-reperfusion injury. ALOX15 promotes the resolution of inflammation under acute conditions by producing specialized proresolving mediators by oxidizing essential fatty acids. Therefore, MAFB in macrophages promotes the resolution of inflammation in ischemic AKI by regulating the expression of Alox15. Moreover, MAFB expression in macrophages is upregulated via the COX-2/PGE2/EP4 pathway in ischemic AKI. Our in vitro assay showed that MAFB regulates the expression of Alox15 under the COX-2/PGE2/EP4 pathway in macrophages. PGE2 mediates the lipid mediator (LM) class switch from inflammatory LMs to specialized proresolving mediators. Therefore, MAFB plays a key role in the PGE2-mediated LM class switch by regulating the expression of Alox15. Our study identified a previously unknown mechanism by which MAFB in macrophages alleviates ischemic AKI and provides new insights into regulating the LM class switch in acute inflammatory conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MafB Transcription FactorArachidonate 15-LipoxygenaseAcute Kidney InjuryMacrophagesDinoprostoneMice, Inbred C57BLReperfusion InjuryAnimalsMiceMice, KnockoutMaleInflammationArachidonate 12-Lipoxygenase

Substanzen

MafB Transcription FactorArachidonate 15-LipoxygenaseDinoprostoneMafb protein, mouseAlox15 protein, mouseArachidonate 12-Lipoxygenase

Autor:innen und Institutionen

  • Department of Anatomy and Embryology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Ph.D. Program in Human Biology, School of Integrative and Global Majors, University of Tsukuba, Tsukuba, Japan.
  • Tsukuba Medical Center Hospital, Tsukuba, Japan.
  • Department of Nephrology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Laboratory for Metabolomics, RIKEN Center for Integrative Medical Science, Yokohama, Japan.
  • Division of Physiological Chemistry and Metabolism, Graduate School of Pharmaceutical Science, Keio University, Tokyo, Japan; and.

ORCID-Profile: Maho Kanai, Teppei Nishino, Dhouha Daassi, Ching-Wei Liao, Zeynab Javanfekr Shahri, Arata Wakimoto, Natalia Gogoleva, Toshiaki Usui, Naoki Morito, Satoru Takahashi, Michito Hamada

Förderung

  • Ministry of Education, Culture, Sports, Science and Technology (MEXT)
  • MEXT | Japan Science and Technology Agency (JST)

Zitieren

APA

Kanai, M., Nishino, T., Daassi, D., Kimura, A., Liao, C. W., Javanfekr Shahri, Z., Wakimoto, A., Gogoleva, N., Usui, T., Morito, N., Arita, M., Takahashi, S., & Hamada, M. (2024). MAFB in Macrophages Regulates Prostaglandin E2–Mediated Lipid Mediator Class Switch through ALOX15 in Ischemic Acute Kidney Injury. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2300844

Vancouver

Kanai M, Nishino T, Daassi D, Kimura A, Liao CW, Javanfekr Shahri Z, et al. MAFB in Macrophages Regulates Prostaglandin E2–Mediated Lipid Mediator Class Switch through ALOX15 in Ischemic Acute Kidney Injury. The Journal of Immunology. 2024. doi:10.4049/jimmunol.2300844

BibTeX
@article{Kanai2024,
  author = {Kanai, Maho and Nishino, Teppei and Daassi, Dhouha and Kimura, Akari and Liao, Ching-Wei and Javanfekr Shahri, Zeynab and Wakimoto, Arata and Gogoleva, Natalia and Usui, Toshiaki and Morito, Naoki and Arita, Makoto and Takahashi, Satoru and Hamada, Michito},
  title = {MAFB in Macrophages Regulates Prostaglandin E2–Mediated Lipid Mediator Class Switch through ALOX15 in Ischemic Acute Kidney Injury},
  journal = {The Journal of Immunology},
  year = {2024},
  doi = {10.4049/jimmunol.2300844}
}
Kostenlos starten →